Document is current
Any future updates will be listed below
-
Authors
Casey, Caroline S. https://orcid.org/0000-0001-8702-4547
Pölkki, Mari https://orcid.org/0009-0003-4798-1512
Suvanen, Elisa K. https://orcid.org/0009-0001-5255-4115
Iso-Mustajärvi, Ilona https://orcid.org/0009-0008-7429-3279
Purmonen, Timo https://orcid.org/0000-0001-7794-7495
Peltonen, Essi J. https://orcid.org/0000-0002-5782-3089
Appel, Camilla K. https://orcid.org/0000-0002-2903-7152
Patel, Niraj J. https://orcid.org/0000-0002-9560-9374
Von Arx, Lill-Brith https://orcid.org/0000-0002-7170-6268
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 26 February 2025
First Online: 6 April 2025
Declarations
:
: Caroline Casey and Niraj Patel are employees of Eli Lilly and Company and holders of Eli Lilly stock. Elisa Suvanen is an employee of Oy Eli Lilly Finland Ab and holder of Eli Lilly stock. Camilla Appel and Lill-Brith Von Arx are employees of Eli Lilly Danmark and holders of Eli Lilly stock. Mari Pölkki, Ilona Iso-Mustajärvi, Timo Purmonen, and Essi Peltonen are employees of Oriola Finland Oy.
: This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki 1964 and its later amendments and that are consistent with Good Pharmacoepidemiology Practices and applicable Finnish laws and regulations. A privacy statement following the European Union General Data Protection Regulation (Intersoft Consulting 2024) was available online for the respondents. The survey, including the pilot, was conducted according to the guidelines of the Finnish National Advisory Board on Research Integrity, which do not require ethics committee approval for surveys targeting respondents aged ≥ 15 years [].Participation in the study was anonymous and entirely voluntary. Respondents provided informed consent for the use of their responses in the study (via a checkbox on the electronic survey) and were able to withdraw consent at any time when completing the survey.
